Contact UsInvestorsCareersMediaScienceContact Us
HomeResponsibilityTransparencyDisclosure of Payments to Members of the PublicDisclosure of Payments to Members of the PublicPfizer engages members of the public, including patients, carers, health economists and others to provide expert advice and guidance on many aspects of the work that we do. For example patients and carers are often engaged to advise on: Health Economists help us understand the economic value of the medicines that we develop and advise us on which outcomes demonstrate the greatest impact of a medicine to society and the economy.

We believe that the disclosure of payments to members of the public is another important step forward in the work we are doing to ensure that the public can have confidence in the way our industry operates. Payments to members of the public are disclosed in an aggregated format to ensure that the privacy of patients, carers and other members of the public are appropriately protected.

Download our methodology note on members of the public reporting
Download our 2022 report on payments to Members of the Public (PDF)


Patient Organisation Funding and Support

Transparency is at the heart of our approach when working with patient organisations, and the interests of patients always come first.


Patient Involvement in Research and Development

Scientific advances in medicine development are increasingly influenced by engagement with patient populations.

PP-UNP-GBR-5473 / June 2023
Science Products Responsibility PartnershipsCareers Privacy Statement Terms of Use Contact UsSitemap Copyright © 2017-2024 Pfizer Limited. PP-UNP-GBR-8108 / January 2024. All rights reserved. Registered in England and Wales No. 526209. Registered office: Ramsgate Road, Sandwich, Kent CT13 9NJ. VAT No. GB201048427. This website is intended for the general public in the UK.